A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
about
sameAs
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophreniaAdjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacynAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersEffects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in ratsTranslational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia.The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human SubjectsTargeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational BiomarkerThe treatment of cognitive impairment in schizophrenia.Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Newer antipsychotics and upcoming molecules for schizophrenia.Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.Potential serotonergic agents for the treatment of schizophrenia.Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery.The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled TrialsUsing built-in functions of Adobe Acrobat Pro DC to help the selection process in systematic reviews of randomised trials.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Tropisetron and its targets in Alzheimer's disease.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
P2860
Q28287576-24ABDAE0-DF0E-4119-B934-709CA1F667A5Q28297813-63C5B673-1E4A-40AD-9A2A-1A9CD7B8CB6AQ30362464-E6BFF3F1-B6CE-494D-84F2-24A381AAB965Q30372351-03BE7725-EFDD-4705-93B6-59020E4EFB10Q30391389-F6F7E386-BA89-4AAA-8934-5568D63F59A1Q30407039-6DA570A0-B0D0-4E48-B651-262603EE3BC6Q30428422-78C7970A-1201-46EB-AF23-4D57FF7529A1Q30455599-90374D4E-3A33-4132-98F9-80C1890E860BQ34274859-088B9228-85B8-4D35-95E9-18D05F3D3E0BQ34879435-66DC0892-27F4-4938-B8DC-9FC15EC2B20CQ35579197-FEFE3B66-AACC-4E51-9C2F-4E39B4AEA602Q36088364-405CEACB-167F-45B4-8F9D-E58F3665DF00Q36243977-2AD5B943-BEA8-4A15-8C28-26E4454C8E96Q36600684-D89CFEA5-4973-47FB-B0F4-81A94003226AQ37258840-9B30BC7D-4F2B-40FA-A4B8-3B4480B57456Q37813206-F75AE4B3-BA8E-485D-9765-0AF0F11B809FQ37954123-D4F69768-E2E6-4D47-A996-420CE58F2C4AQ38066550-CF4B284A-F551-4A82-A13A-48A2DB112E6BQ38094930-5D65622D-41BC-4258-9366-B0E5CABD752DQ38171876-58369FC6-F461-4B19-9385-1487DECFBB25Q38635792-FA3E4AF4-2B78-42B1-B7F2-56B9AD849157Q38837028-42E7174E-1869-4B25-9108-0DE1FEF32B69Q38934855-CF62C894-25B5-4530-9F57-99E9C0B585BDQ41687338-3D9FD5CC-9C3B-4C5D-BADE-32781323F89EQ42577738-7A953A13-DF28-4DA1-9167-295C7C38D4E1Q47127039-6126A5B0-3012-4F17-8A85-060DFDFBF6B5Q50612380-140B4191-DBCB-4CA3-A89D-A09BC29F50CBQ58561523-777EC538-4C03-42E9-B288-4AD717CFD06C
P2860
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomised, double-blind, pl ...... in patients with schizophrenia
@ast
A randomised, double-blind, pl ...... in patients with schizophrenia
@en
A randomised, double-blind, pl ...... in patients with schizophrenia
@en-gb
A randomised, double-blind, pl ...... in patients with schizophrenia
@nl
type
label
A randomised, double-blind, pl ...... in patients with schizophrenia
@ast
A randomised, double-blind, pl ...... in patients with schizophrenia
@en
A randomised, double-blind, pl ...... in patients with schizophrenia
@en-gb
A randomised, double-blind, pl ...... in patients with schizophrenia
@nl
prefLabel
A randomised, double-blind, pl ...... in patients with schizophrenia
@ast
A randomised, double-blind, pl ...... in patients with schizophrenia
@en
A randomised, double-blind, pl ...... in patients with schizophrenia
@en-gb
A randomised, double-blind, pl ...... in patients with schizophrenia
@nl
P2093
P2860
P921
P3181
P356
P1476
A randomised, double-blind, pl ...... in patients with schizophrenia
@en
P2093
Akihiro Shiina
Goro Fukami
Kenji Hashimoto
Masaomi Iyo
Michiko Nakazato
Mihisa Fujisaki
Nobuhisa Kanahara
Tadashi Haraguchi
Tadashi Hasegawa
Taisuke Yoshida
P2860
P2888
P3181
P356
10.1186/1744-859X-9-27
P407
P577
2010-01-01T00:00:00Z
P6179
1008859336